Semaglutide Guidance Updated with New Safety Warnings

Recent updates for semaglutide, a drug used for type 2 diabetes and weight management, include expanded prescribing guidance and new safety warnings. These warnings highlight potential gastrointestinal side effects such as ileus, pancreatitis, and gallbladder disease. Patients are advised to consult healthcare providers about their medical history and the risks associated with unreviewed compounded versions.